PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
March 22, 2012 | ISSUE NUMBER 243 VOL 8

Special Feature
Industry Off the Hook? Pharm Exec's 8th Annual Press Survey
Our annual press audit finds that the big news in 2011 for pharma was ... no news! The year was the quietest for big daily newspaper coverage of the pharmaceutical industry since we began tracking the data in 2004 ...Read More

Advertisement

Legal
Prometheus Decision a Harbinger for Myriad?
Judging the Prometheus patents invalid, the Supreme Court may have shown its hand on the upcoming Myriad Genetics case ...Read More

Comment
Journey from Patent Filing to Drug Approval Harder Than Ever
Data from law firm Withers & Rogers shows how the numbers of patent filings from the ten leading pharma companies has dropped in recent years. Only 129 “patent families” of drugs in leading markets were sought by the top 10 drug companies in 2009, down from 189 in 2007. Combined with other reports suggesting that regulatory approval has also become harder to obtain, the upshot is that Big Pharma is struggling to refill drug pipelines as their older products come off patent ...Read More

World Health
Industry Optimism for Advancing TB Research
Scientists are optimistic new combination regimens will improve TB treatment and reduce drug resistance, writes Jill Wechsler
...Read More

Advertisement
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
On-Demand Webcast
Click here

// MichBio (Ann Arbor, MI) announced the appointment of Wendy Wendel (formerly Wendy Ventura) as Director, Marketing & Communications. // Physicians Interactive (Marlborough, MA) named Gautam Gulati as Chief Medical Officer and Senior Vice President of Product Management, and Joe Caso as Executive Vice President of New Business Development. // Catalent Pharma Solutions, Inc. (Somerset, NJ) announced the appointment of Jeremie Trochu to the newly-created position of Vice President, Commercial Excellence.
Advertisement
Utilization of Rasch Measurement Models for Assessing Validity: A Mixed Methods Approach
On-Demand Webcast
Click here

April 16–17: CBI's 3rd Annual West Cost Forum on Sunshine, State Laws and Aggregate Spend
New York, NY


April 26–27: 11th Annual Patient Adherence Forum
Philadelphia, PA


May 7–8: Bio/Pharma Forum on Regulatory Policy
Washington, DC



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

Advertisement


Survey
How important is it for your company to appoint a social media 'tsar'?

Click To Vote
 
Quick Links

How Can We Fix the FDA?

The Big Data Drawback

Patient Assistance Programs: Are They Still Relevant?


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive